Anorexiants Market to Reach US$1,911.25 Million by 2034 at a CAGR of 4.71%
The growing prevalence of obesity, increasing diagnosis of weight-related chronic conditions, and expanding physician-led pharmacological interventions are supporting demand for appetite-control therapies. Greater emphasis on supervised weight management is also encouraging the use of regulated and clinically appropriate treatment options. … Read more